Dating and relationships raise specific emotional and practical questions for people with Crohn’s (disclosure, symptom management, medication side effects). This article offers real-world tips to help people navigate...

Based on the title and source metadata, this appears to be a patient education related to Crohn's disease, Inflammatory bowel disease, and Mental health and quality of life. The original article is from msn.com.

Mental health conditions (depression, anxiety, ADHD) appear to increase before and after IBD diagnosis, suggesting psychological care may be needed earlier in the diagnostic pathway and long term.

The study highlights a bacterial gene that helps adherent-invasive E. coli (AIEC) colonize the gut — a mechanism that has been linked to Crohn's disease. Understanding how AIEC colonizes could guide future research into...

The findings show earlier and more frequent use of imaging, endoscopic assessment, anti-TNF therapy, and seton placement for active perianal fistulizing Crohn’s disease over recent years — practices that may affect...

People with IBD are at higher risk for colorectal cancer; identifying stromal genes that track inflammation-driven EMT could help researchers find biomarkers or targets that explain how chronic inflammation promotes...

A blood test (serum REG3α) may help identify people at higher risk of developing complicated Crohn's disease years before diagnosis and predict progression in established disease, which could inform monitoring or early...

Patients with UC and their clinicians may encounter CMV on colon biopsy testing; this study suggests CMV detection is linked with higher mucosal inflammation and a less favorable long-term course, highlighting a...

Physical activity may be a modifiable factor that could improve fitness, inflammation, symptoms like fatigue, and quality of life in children with IBD. This trial will provide objective, randomized data relevant to...

Awareness events connect people with Crohn’s and ulcerative colitis to local resources, support networks, and advocacy efforts. They can raise visibility and reduce isolation for people living with IBD.

CAR-Treg and Treg-cell therapies aim to specifically suppress harmful gut inflammation and could offer a new treatment option for people whose IBD does not respond to current drugs. Right now this is early-stage work —...

Finding reliable blood biomarkers for ulcerative colitis activity could make monitoring disease flares easier and less dependent on invasive tests. NGAL and S100A12 rising with active disease suggests they might help...

Researchers identified licochalcone B as a compound that reduced inflammation and repaired gut barrier in a mouse colitis model by affecting PI3K/AKT signaling and purine metabolism. For people following IBD research,...

Based on the title and source metadata, this appears to be a patient education related to Crohn's disease, Inflammatory bowel disease, and Tests and monitoring. The original article is from msn.com.

This is the official FDA drug label for dexamethasone sodium phosphate. It names ulcerative colitis and regional enteritis (Crohn’s disease) among indications where systemic corticosteroids can be used, so it’s relevant...

This FDA drug-label update describes approved uses and safety warnings for tofacitinib, a JAK inhibitor used in immune-mediated diseases including ulcerative colitis. The boxed warnings highlight serious infection and...

Sarcopenia (loss of muscle mass/strength) was common among hospitalized adults with active UC and linked to inflammation, changes in blood metabolites (bile acids, acylcarnitines), and shifts in the gut microbiome.

The work highlights macrophage metabolic programs and specific genes that may help classify UC molecular subtypes and suggest candidate biomarkers or therapeutic targets related to macrophage-driven inflammation.

The work links a PD risk gene (LRRK2 G2019S) to increased intestinal NET formation and enteric α-synuclein in mouse colitis, suggesting a neutrophil-mediated inflammatory route by which gut inflammation and microbiota...

AIEC bacteria have been linked to Crohn’s disease; this study identifies a bacterial gene (rfaG) that helps AIEC express adhesins and colonize the gut in experimental models, which could point to future research paths...

If AJs and E-cadherin signaling influence intestinal inflammation, that could change how researchers think about IBD causes and point to new molecular targets for study.

The study links a common environmental chemical (BPA) to worse epithelial injury and inflammation in colitis models, highlighting a potential environmental contributor to IBD-relevant epithelial dysfunction and...

PSC — a serious bile-duct disease linked to IBD — was found on MRCP in about 1 in 10 people at IBD diagnosis, often without abnormal liver blood tests. Early radiological detection could affect monitoring and specialist...

Based on the title and source metadata, this appears to be a clinical study related to Inflammatory bowel disease and Research and clinical trials. The original article is from fingerlakes1.com.

The study suggests that anti‑TNF treatment in IBD is associated with weaker and less cross‑reactive antibody and memory B‑cell responses after COVID‑19 booster vaccination, which may reduce durability of protection and...

Researchers used machine learning and molecular docking plus small animal tests to link a common plasticizer (DEP) with molecular changes seen in pediatric Crohn’s disease. This could point to environmental exposures...

This is the official FDA label text for dexamethasone, so it clarifies approved uses and gives practical dosing and tapering guidance. It explicitly names "regional enteritis and ulcerative colitis," which matters to...

This label update confirms current FDA prescribing information for sulfasalazine delayed‑release tablets, which many people with ulcerative colitis may be prescribed for induction and maintenance of remission.

Label updates list safety warnings and monitoring steps that can affect people taking APRISO (mesalamine) for ulcerative colitis. Knowing these helps patients and clinicians watch for serious side effects and manage...

This FDA label page documents official prescribing information for SOLU-CORTEF (hydrocortisone), including explicit gastrointestinal/IBD indications (regional enteritis and ulcerative colitis) and IV/IM dosing guidance.

Herpes zoster is more common and can be more severe in people with IBD, especially those on certain immunosuppressive drugs. Understanding therapy-specific risks and vaccine options can help prevent painful...

Medication adherence affects how well IBD maintenance treatment works. This study highlights the everyday challenges and beliefs that shape whether people stick with prescribed therapies, which can help clinicians and...

Based on the title and source metadata, this appears to be a clinical study related to Ulcerative colitis, Inflammatory bowel disease, and Diet and lifestyle. The original article is from Journal of Functional Foods.

Many people with IBD change their diets and avoid foods they believe trigger flares. Differences between Crohn’s disease and ulcerative colitis were observed, and many—especially those with UC—reported not receiving...

This report highlights that Langerhans cell histiocytosis can present with intestinal ulcerations mimicking IBD and may be missed if standard IBD treatments don’t help. Patients with persistent bleeding or nonresponsive...

Early feeding after colorectal surgery can speed recovery and shorten hospital stay and appears safe for most patients with IBD when used within ERAS programs.

Cure8 could only read part of this source from dermatologytimes.com, so this card uses cautious topic tags instead of a full summary. It is tagged for Crohn's disease and Complications.

Art made by someone with Crohn’s disease was publicly recognized and installed in the college president’s office, which can raise awareness and validate patient experiences. The piece also touches on the emotional and...

Cure8 found this source from onlinelibrary.wiley.com, but the page could not be read reliably yet. It is tagged for Research and clinical trials. Open the original article for the full details.

Vitamin D deficiency is common in people with IBD and this study suggests correcting deficiency may help rebalance immune cells and the microbiome—potentially supporting inflammation control alongside standard...

People with COPD can have coexisting type‑2 inflammatory conditions, and those conditions become more common with higher blood eosinophil counts. Knowing this may influence clinicians’ attention to extra‑pulmonary T2...

Many pediatric patients with IBD receive infusion biologic therapies. Shifts in where those infusions happen (driven by payer policies) can create administrative burdens and raise concerns about safety and care...

Protease and serpin activity affect the gut barrier, immunity, and microbial ecology—processes central to IBD. Integrating these pathways could help identify biomarkers or targets that explain why IBD varies between...

Preclinical results suggest a fermented yak milk–derived probiotic strain may protect against colitis in mice by improving barrier function, lowering inflammatory cytokines, and changing the gut microbiome—mechanisms...

Iliopsoas abscess is an uncommon but serious penetrating complication of Crohn’s disease that can present with non-specific symptoms and be missed. The review compiles case-level evidence about presentation, diagnosis,...

People with Crohn’s who have had ileal or ileocolic surgery often worry about needing another operation; this study seeks clinical and biomarker predictors to estimate that risk. Understanding predictors could help...

Patients and clinicians often seek adjunctive options to improve symptoms, quality of life, or reduce treatment burden. This trial tests whether Bacillus spore probiotics added to standard care can provide measurable...

Mapping microbes and metabolites directly from different gut regions could reveal location-specific changes linked to IBD activity and help researchers develop better biomarkers or targeted treatments.